Literature DB >> 26580685

Novel homozygous mutations in the EVC and EVC2 genes in two consanguineous families segregating autosomal recessive Ellis-van Creveld syndrome.

Abdul Aziz1, Syed I Raza, Salman Ali, Wasim Ahmad.   

Abstract

Ellis-van Creveld syndrome (EVC) is a rare developmental disorder characterized by short limbs, short ribs, postaxial polydactyly, dysplastic nails, teeth, oral and cardiac abnormalities. It is caused by biallelic mutations in the EVC or EVC2 gene, separated by 2.6 kb of genomic sequence on chromosome 4p16. In the present study, we have investigated two consanguineous families of Pakistani origin, segregating EVC in autosomal recessive manner. Linkage in the families was established to chromosome 4p16. Subsequently, sequence analysis identified a novel nonsense mutation (p.Trp234*) in exon 8 of the EVC2 gene and 15 bp duplication in exon 14 of the EVC gene in the two families. This further expands the mutations in the EVC or EVC2 genes resulting in the EVC syndrome.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26580685     DOI: 10.1097/MCD.0000000000000104

Source DB:  PubMed          Journal:  Clin Dysmorphol        ISSN: 0962-8827            Impact factor:   0.816


  3 in total

1.  Ellis-van Creveld syndrome and profound deafness resulted by sequence variants in the EVC/EVC2 and TMC1 genes.

Authors:  Muhammad Umair; Heide Seidel; Ishtiaq Ahmed; Asmat Ullah; Tobias B Haack; Bader Alhaddad; Abid Jan; Afzal Rafique; Tim M Strom; Farooq Ahmad; Thomas Meitinger; Wasim Ahmad
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

2.  Identification of a novel EVC variant in a Han-Chinese family with Ellis-van Creveld syndrome.

Authors:  Xiangjun Huang; Yi Guo; Hongbo Xu; Zhijian Yang; Xiong Deng; Hao Deng; Lamei Yuan
Journal:  Mol Genet Genomic Med       Date:  2019-07-23       Impact factor: 2.183

3.  Interpretation of Autosomal Recessive Kidney Diseases With "Presumed Homozygous" Pathogenic Variants Should Consider Technical Pitfalls.

Authors:  Haiyue Deng; Yanqin Zhang; Yong Yao; Huijie Xiao; Baige Su; Ke Xu; Na Guan; Jie Ding; Fang Wang
Journal:  Front Pediatr       Date:  2020-04-17       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.